Kirsi Manz

Wissenschaftliche Mitarbeiterin

University Medicine Greifswald
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (21)

Year:

2026

Zusammenfassung Seit langem ist der grundsätzliche Zusammenhang zwischen Arbeitslosigkeit (ALO) und gesundheitlichen Beeinträchtigungen bekannt. Dabei stellen sich Fragen nach den häufigsten Erkrankungen unter Menschen in ALO sowie darauf basierende (etwaige) Leistungseinbußen. Ziel der Studie ist es, die 20 häufigsten Erkrankungen von im Ärztlichen Dienst (ÄD) der Bundesagentur für Arbeit (BA) untersuchten Menschen in ALO darzustellen sowie (etwaige) darauf basierende Leistungseinbußen für den (allgemeinen) Arbeitsmarkt und weitere assoziierte Faktoren zu analysieren. Für die vorliegende mehrjährige Querschnittsstudie (2016–2021) wurden die 20 häufigsten Erkrankungen/ Diagnosen aller (n=4 249 028) sozialmedizinischer Begutachtungen des ÄD der BA mit den jeweiligen Erst- und Zweitdiagnosen auf der Basis von ICD-10-Codes sowie damit assoziierte Faktoren (Geschlecht, Alter, Leistungsbild) aus Datenbanken des ÄD analysiert. Zur Analyse der Daten wurde neben deskriptiver Statistik binäre logistische Regression genutzt. Von den jährlich rund 500 000 im ÄD begutachteten KundInnen erhielten nahezu alle (2016: 90,1%; 2021: 99,5%) eine Erstdiagnose. Von den 20 häufigsten Diagnosen stammt die Hälfte aus dem Bereich der psychischen Erkrankungen. Am häufigsten wurden depressive Episoden (n=416 531; 10,2%), rezidivierend depressive Störungen (n=415 651; 10,1%) und (andere) Angststörungen (n=169 112; 4,6%) diagnostiziert. Bei den nicht-psychiatrischen Störungen belegen Rückenschmerzen (n=243 389; 6,6%), essentielle Hypertonien (n=146 316; 4,0%) und (sonstige) Bandscheibenschäden (n=91 861; 2,2%) die ersten drei Plätze. Alter und Geschlecht differieren je nach Erkrankung signifikant. Insgesamt wurden 33,9% aller begutachteten Personen als leistungsunfähig (<3 Std./Tag) eingestuft, wobei psychische Erkrankungen den häufigsten Grund dafür darstellen, dabei am häufigsten mit 63,6% Schizophrenien. Psychische Erkrankungen sind unter von ALO betroffenen Menschen besonders häufig. Dies sollte bei der ärztlichen Versorgung sowie der Arbeitsmarktintegration Beachtung finden. Die Vernetzung von arbeitsmarktlichen und gesundheitlichen und insbesondere psychiatrischen Hilfen scheint sinnvoll, um psychische Erkrankungen und ALO möglichst rasch und nachhaltig zu überwinden. Stichworte: Arbeitslosigkeit, Erkrankungen, Epidemiologie, Leistungsunfähigkeit, Langzeitarbeitslosigkeit

Year:

2026

Year:

2026

Year:

2026

Polycythemia vera (PV) is a myeloproliferative neoplasm associated with increased thromboembolic (TE) risk and hematologic complications. Hydroxyurea (HU) serves as the most frequently used first-line cytoreductive therapy worldwide; however, resistance to HU (HU-RES) develops in a significant subset of patients, leading to increased morbidity and necessitating alternative treatments. This study, part of the PV-AIM project, employed machine learning techniques on real-world evidence (RWE) from the Optum® EHR database containing 82.960 PV patients to identify baseline predictors of HU-RES within the first 6–9 months of therapy. Using a Random Forest model, the study analyzed data from 1850 patients, focusing on laboratory parameters and clinical characteristics. Key predictive markers included red cell distribution width (RDW) and hemoglobin (HGB), showing the strongest association with HU-RES. A synergistic interaction between RDW and HGB was identified, enabling TE risk stratification. This study provides a robust framework for early detection of HU-RES using readily available clinical data, facilitating timely intervention. These findings underscore the importance of personalized treatment approaches in managing PV and highlight the utility of machine learning in enhancing predictive accuracy and clinical outcomes. Based on the results of PV-AIM we initiated an open-label, prospective, single-arm, interventional, phase IV study (HU-F-AIM) evaluating HU-resistance/intolerance. Validation of predictive biomarkers may facilitate identification of patients at risk of HU resistance who may benefit from alternative treatment options, possibly preventing ongoing phlebotomy during HU treatment, a frequent therapeutic choice in high-risk PV associated with early disease progression and increased thromboembolic complications. We propose an updated terminology that differentiates between true molecular resistance and clinical resistance, that may indicate the requirement for alternative therapeutic strategies.

Year:

2025

Myeloproliferative neoplasms (MPN) are associated with a variety of symptoms that severely impact patients’ quality of life and ability to perform daily activities. Recent studies showed differences in the perception of physician- versus patient-reported symptom burden. However, studies directly comparing patient- and physician-reported ratings are lacking. Here, a retrospective analysis on symptom burden of 3979 MPN patients of the Bioregistry of the German Study Group for MPN was conducted to intra-individually compare physician and patient reports collected at the same time. Cohen’s kappa was calculated to assess the degree of agreement between patient and physician reports. Factors influencing baseline symptom severity were identified using linear regression and adjusted Cox models were calculated to investigate the effect of symptom burden on survival. MPN patients had a high symptom burden, which neither decreased over time nor upon cytoreductive therapy. All symptoms were more frequently reported by patients compared to physicians. Agreement remained low and only slightly improved when considering a higher threshold for patient symptom severity. Patients with severe symptom burden had inferior survival compared to patients with less severe symptoms. Assessment of symptom burden in MPN is therefore insufficient and patient-reported outcome tools need to be implemented into clinical routine.

Year:

2025

Year:

2025

Background The interactions between unemployment and mental health are complex. However, broad and current epidemiological data about the mental health status of unemployed individuals in Germany are scarce. This study aimed to evaluate the prevalence rates of mental disorders and work ability among all unemployed people who underwent socio-medical assessment by the Federal Employment Agency (FEA). Methods Socio-medical assessments between 2016 and 2021 were taken from the FEA database and analyzed regarding sociodemographic characteristics, mental disorders and work ability. Standard descriptive statistics were used to analyze the data. Results A total of 4,249,028 unemployed individuals were assessed. Of these, 2,213,048 persons (52.1%) had at least one psychiatric diagnosis (mean age 40.6 ± 13.5 years, 51.7% female). Mood disorders (53.9%), neurotic, stress-related and somatoform disorders (43.9%), as well as substance use disorders (15.3%) showed the highest prevalence rates among mental disorders and accounted for about 80% of all psychiatric diagnoses. About 40% of them were evaluated to be able to work full time. Conclusions Psychiatric morbidity among unemployed people is high. However, a significant proportion of them was assessed to be able to return to the labor market. Therefore, close collaborations between unemployment agencies and mental health care institutions as well as specific re-integration programs including supported job placement and vocational training, long-term job coaching as well as integrated mental health care are required in order to improve mental health status, prevent further chronification, avoid labor market exit, and increase employment rate.

Year:

2025

Background The aim of this study is the analysis of cancer incidence and mortality among the firefighters of the municipal fire brigade in the city of Neubrandenburg in Germany. Methods To asses cancer risk standardized incidence ratios and standardized mortality ratios were computed. The risk of the firefighter cohort was compared to the risk of two reference populations: the county Mecklenburg Lake District, where the city of Neubrandenburg is located, and the federal state Mecklenburg-Western Pomerania. Results Results are based on data from 100 firefighters. No statistically significant results were observed for the incidence or mortality of all cancers (ICD-10 C00-C97 without C44). The SIR and SMR for bladder cancer were significantly elevated. Conclusion The overall cancer incidence and mortality among Neubrandenburg’s firefighters were not higher than among the reference population. The increased incidence and mortality from bladder cancer are in line with published results, especially with the monograph by the International Agency for Research on Cancer on occupational exposure as a firefighter.

Year:

2025

Introduction Newborn screening for hearing impairment (NHS) is a crucial public health issue worldwide. Often, a two-stage screening with two different testing approaches is used. We aimed to investigate the optimal screening algorithm, based on data from the literature published in the last 30 years. A particular focus of the study was to synthesize the existing evidence on two-stage newborn hearing screening regarding the refer rate (RFR), the percentage of children that did not pass the second test or were lost after the first test. Methods We searched MEDLINE and Scopus for studies on two-stage NHS using transient evoked otoacoustic emissions (TEOAE) or automated auditory brainstem response (AABR). All studies on newborns who received their first test as an inpatient and a second test up to 1 month later were eligible. Random effects meta-analysis was performed to estimate RFR. Risk of bias was assessed using QUADAS-II. The unfunded study was registered in PROSPERO (CRD42023403091, available at https://www.crd.york.ac.uk/PROSPERO/view/CRD42023403091 ). Results Eighty-five study protocols, including over 1,120,000 newborns, met the inclusion criteria. Certainty in the evidence was rated as moderate. Discussion Strategies that did not involve changes to the screening method had a lower RFR. AABR-AABR: RFR = 1.3% [95% confidence interval (CI): 0.9, 1.8%], TEOAE-TEOAE: RFR = 2.7% (CI: 2.2, 3.2%), TEOAE-AABR: RFR = 3.9% (CI: 2.9, 5.1%), AABR-TEOAE: 5.9% (CI: 5.0, 6.9%). Consequently, where feasible, changing the screening method at the second screening should be avoided in order to minimize the number of follow-up examinations.

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (10)

Sven Voigtländer

Senior Researcher

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY
View details

Uli Fischer

Director

Catholic University of Applied Social Sciences

GERMANY
View details

Claudia Pieper

Head of Unit „Prevention and Health Promotion“

University Hospital Essen

GERMANY
View details

Jan Krönke

Professor

Charité - Universitätsmedizin Berlin

GERMANY
View details

Valerio De Stefano

Full Professor of Hematology

Università Cattolica del Sacro Cuore

ITALY
View details

Florian Heidel

Professor, Director and Chair

Hannover Medical School

GERMANY
View details

Andreas G. Franke

University of Applied Labour Studies

GERMANY
View details

Gabriele Robers

University Hospital Düsseldorf

GERMANY
View details

Lars Schwettmann

Head of Division Health Economics

Carl von Ossietzky Universität Oldenburg

GERMANY
View details

Steffen Koschmieder

RWTH Aachen University

GERMANY
View details